Square Enix to auction Symbiogenesis NFTs

Renowned video game publisher Square Enix has unveiled the NFT auctioning schedule for its blockchain-backed game Symbiogenesis.

In a Nov. 24 post on X (formerly Twitter), Final Fantasy creator Square Enix shared its plans to sell Symbiogenesis NFTs in three rounds.

Per the announcement, the first auction will occur from Nov. 27 to Nov. 28, with the second spanning from Nov. 30 to Dec. 1. The final round of auctions will occur between Dec. 2 and Dec. 3.

Five hundred character NFTs will be launched for Chapter 1 of Symbiogenesis, with the initial auction introducing ten unique NFT characters to the ecosystem. The second auction will feature 90 additional characters, and the final round will contribute 400 NFT characters to the game. 

According to Square Enix, the first phase will be exclusively available to stakeholders, indicating initial investors-only participation during the Nov. 27-28 phase. 

However, subsequent phases will open to those participating in a permission-based entry campaign. This campaign ran from Nov. 7 to Nov. 21 and involved collectors participating in various quizzes and a treasure hunt within a prototype of the Symbiogenesis universe.

Symbiogenesis is a culmination of Square Enix president Yosuke Matsuda’s desire to get into web3 gaming, which he expressed at the start of the year. 

In July, the company partnered with blockchain gaming firm Enjin to produce NFTs tied to physical trading cards and action figures based on characters from Final Fantasy VII. 

Square Enix describes Symbiogenesis as a “digital collectible art project,” promising an engaging, narrative-driven gaming experience. It revolves around characters and items minted as Ethereum (ETH) NFTs on the Polygon (MATIC) network and is slated for launch in December, following the initial NFT mint.


Follow Us on Google News

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox, everyday.

We don’t spam! Read our [link]privacy policy[/link] for more info.